Mah Sing obtains certification to export gloves to Europe - MIDA | Malaysian Investment Development Authority
contrastBtngrayscaleBtn oku-icon


plusBtn crossBtn minusBtn


This site
is mobile


Mah Sing obtains certification to export gloves to Europe

Mah Sing obtains certification to export gloves to Europe

03 Jun 2021

Mah Sing Group Bhd’s wholly-owned subsidiary Mah Sing Healthcare Sdn Bhd has received approval from European Conformity (Conformitè Europëenne [CE Mark]) for its powder-free nitrile examination gloves and powder-free latex examination gloves, which would facilitate the company to tap into the export market to the European region.

Concurrently, Mah Sing Healthcare also obtained the certificate issued by TÜV Rheinland LGA Products GmbH certifying that the company has established and applies a quality management system for medical devices, and is in compliance with EN ISO 13485:2016 standard for the manufacturing and distribution of natural rubber latex examination gloves powder free, non-sterile and nitrile butadiene rubber (NBR) examination gloves powder free, non-sterile, the group said in a statement.

The CE mark is recognised by European (EU) member states that the product meets all appropriate EU requirements including relevant European product directive, harmonised performance and safety standards, and is fit for its purpose and will not endanger lives or property.

Meanwhile,TÜV Rheinland is one of the world’s leading testing service providers, with nearly 150 years of experience. As an independent third party, TÜV Rheinland tests technical systems, products and services, supports projects and tests processes for companies and organisations.

The EN ISO 13485:2016 certification reflects Mah Sing’s commitment to enforce a quality management system during the production of gloves in the factory, benchmarking against the global standard.

Mah Sing founder and group managing director Tan Sri Leong Hoy Kum said this marks a step forward for the group to tap the global glove market.

Mah Sing Healthcare has commenced operation at its first glove manufacturing factory in Kapar, Klang, with the first shipment of gloves delivered this month.

Looking ahead, the group expects structural increase in glove usage as a result of new norms, fears of re-infection, higher health awareness and hygiene compliance requirements for healthcare and non-healthcare sectors, and this will continue to support strong demand for the gloves post-pandemic.

Mah Sing shares price dropped one sen to close at 90.5 sen, for a market capitalisation of RM2.2 billion. There were 4.87 million shares traded today.

Source: The Edge Markets